Project Number 1R44AG079777-01 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for A physiologically relevant pre-clinical drug screening platform for Alzheimer's Disease and Traumatic Brain Injury with integrated stretchable microelectrodes Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 1. Research Resources and Enabling Technologies to Accelerate Therapy Development a. Enabling Technologies Researcher and Organization Principal Investigator GRAUDEJUS, OLIVER Principal Investigator First Name OLIVER Principal Investigator Last Name GRAUDEJUS Awardee Organization BMSEED, LLC Awardee State Arizona Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $449,997 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
